Given these findings, this study shows that the inhibition of p53 can block glycerol-mediated AKI by using pharmacological instead of genetic inhibitory approaches, which further supports that p53 played a pivotal role in renal tubular injury when challenged with glycerol. The gene discussed is TP53; the disease is acute kidney injury.